The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Intersurgical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Intersurgical Ltd. (Intersurgical) is a designer, manufacturer, and supplier of a range of medical devices for respiratory support. The company offers airway management products, oxygen and aerosol therapy products, critical care systems, anesthesia breathing systems and carbon dioxide absorbents. Its products include i-gel, respiratory humidifier, breathing filters, closed suction systems, CPAP devices, atomistion devices, anesthetic masks, endoscopy masks and oxygen therapy accessories, among others. Inter surgical markets products through subsidiaries and a network of distributors in North America, Africa, Europe, and Asia-Pacific. Intersurgical is headquartered in Wokingham, Berkshire, the UK. Key subsidiaries of Intersurgical include Intersurgical Japan, Intersurgical China, Pulmodyne, Intersurgical Philippines and Intersurgical Taiwan.
The key metrics of Intersurgical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Intersurgical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Intersurgical.
For a detailed understanding of the performance of Intersurgical, buy the report here.